These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 32724452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The TGFβ/Notch axis facilitates Müller cell-to-epithelial transition to ultimately form a chronic glial scar.
    Conedera FM, Pousa AMQ, Mercader N, Tschopp M, Enzmann V.
    Mol Neurodegener; 2021 Sep 30; 16(1):69. PubMed ID: 34593012
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. RO4929097, a Selective γ-Secretase Inhibitor, Inhibits Subretinal Fibrosis Via Suppressing Notch and ERK1/2 Signaling in Laser-Induced Mouse Model.
    Zhang C, Qin S, Xie H, Qiu Q, Wang H, Zhang J, Luo D, Zhang J.
    Invest Ophthalmol Vis Sci; 2022 Sep 01; 63(10):14. PubMed ID: 36155746
    [Abstract] [Full Text] [Related]

  • 7. Bone morphogenetic protein 7 regulates reactive gliosis in retinal astrocytes and Müller glia.
    Dharmarajan S, Gurel Z, Wang S, Sorenson CM, Sheibani N, Belecky-Adams TL.
    Mol Vis; 2014 Sep 01; 20():1085-108. PubMed ID: 25253985
    [Abstract] [Full Text] [Related]

  • 8. Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Müller cell ablation.
    Shen W, Lee SR, Araujo J, Chung SH, Zhu L, Gillies MC.
    Glia; 2014 Jul 01; 62(7):1110-24. PubMed ID: 24687761
    [Abstract] [Full Text] [Related]

  • 9. Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097.
    Wang L, Dai G, Yang J, Wu W, Zhang W.
    Med Sci Monit; 2018 Jun 14; 24():4046-4053. PubMed ID: 29899322
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-myeloma effect of pharmacological inhibition of Notch/gamma-secretase with RO4929097 is mediated by modulation of tumor microenvironment.
    Pisklakova A, Grigson E, Ozerova M, Chen F, Sullivan DM, Nefedova Y.
    Cancer Biol Ther; 2016 May 03; 17(5):477-85. PubMed ID: 26934342
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Notch signaling modulates proliferative vitreoretinopathy via regulating retinal pigment epithelial-to-mesenchymal transition.
    Zhang J, Yuan G, Dong M, Zhang T, Hua G, Zhou Q, Shi W.
    Histochem Cell Biol; 2017 Mar 03; 147(3):367-375. PubMed ID: 27600720
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Notch prevents transforming growth factor-beta-assisted epithelial-mesenchymal transition in cultured limbal progenitor cells through the induction of Smad7.
    Tsai TH, Sun MH, Ho TC, Ma HI, Liu MY, Tsao YP.
    Mol Vis; 2014 Mar 03; 20():522-34. PubMed ID: 24791137
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties.
    Luistro L, He W, Smith M, Packman K, Vilenchik M, Carvajal D, Roberts J, Cai J, Berkofsky-Fessler W, Hilton H, Linn M, Flohr A, Jakob-Røtne R, Jacobsen H, Glenn K, Heimbrook D, Boylan JF.
    Cancer Res; 2009 Oct 01; 69(19):7672-80. PubMed ID: 19773430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.